Kindred Biosciences

$3.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-5.68%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell KIN and other stocks, options, and ETFs commission-free!

About KIN

Kindred Biosciences, Inc. Common Stock, also called Kindred Biosciences, is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. Read More The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. The listed name for KIN is Kindred Biosciences, Inc. Common Stock.

CEO
Richard H. Chin
Employees
156
Headquarters
Burlingame, California
Founded
2012
Market Cap
137.40M
Price-Earnings Ratio
Dividend Yield
Average Volume
165.40K
High Today
$3.74
Low Today
$3.47
Open Price
$3.70
Volume
215.58K
52 Week High
$11.93
52 Week Low
$3.11

Collections

KIN Earnings

-$0.45
-$0.10
$0.25
$0.60
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Nov 9, After Hours

You May Also Like